Position
Creative Planning in Opus Genetics, Inc.
Back to the book · All holders of IRD
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $326K$2.01 → $4.55
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 128.4K | $258K | — | — | — | 0.0% |
| Q1 2026 | 128.4K | $584.1K | $4.55 | $326K | $0 | 0.0% |